{"id":170458,"date":"2025-08-21T08:55:41","date_gmt":"2025-08-21T12:55:41","guid":{"rendered":"https:\/\/44.250.171.167\/?p=170458"},"modified":"2025-08-25T01:34:31","modified_gmt":"2025-08-25T05:34:31","slug":"aarti-pharmalabs-q1-fy26-earnings-results","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/aarti-pharmalabs-q1-fy26-earnings-results\/","title":{"rendered":"Aarti Pharmalabs Q1 FY26 Earnings Results"},"content":{"rendered":"<p>Aarti Pharmalabs Ltd, incorporated in 2019, is a manufacturer of pharmaceuticals and nutraceuticals. Presenting below are its <a href=\"https:\/\/www.bseindia.com\/xml-data\/corpfiling\/AttachHis\/0062c62b-b124-472a-8148-baa7a1f61e66.pdf\" target=\"_blank\" rel=\"noopener\">Q1 FY26<\/a> Earnings Results.<\/p>\n<h2><strong>Q1 FY26 Earnings Results<\/strong><\/h2>\n<ul>\n<li><strong>Revenue:<\/strong> \u20b9386 crore, down 30.45% year-on-year (YoY) from \u20b9555 crore in Q1 FY25.<\/li>\n<li><strong>Total Expenses:<\/strong> \u20b9323 crore, down 33.26% YoY from \u20b9484 crore.<\/li>\n<li><strong>Consolidated Net Profit (PAT):<\/strong> \u20b950 crore, down 9.09% from \u20b955 crore in the same quarter last year.<\/li>\n<li><strong>Earnings Per Share (EPS):<\/strong> \u20b95.46, down 10.78% from \u20b96.12 YoY.<\/li>\n<\/ul>\n<h2><strong>Operational &amp; Strategic Update<\/strong><\/h2>\n<ul>\n<li><strong>Revenue Decline:<\/strong> Revenues fell significantly by over 30%, reflecting reduced sales volumes or delayed orders in the pharmaceuticals and nutraceuticals space.<\/li>\n<li><strong>Expense Reduction:<\/strong> Expenses declined by over 33%, slightly outperforming revenue reduction and mitigating profit impact.<\/li>\n<li><strong><a href=\"https:\/\/www.bseindia.com\/xml-data\/corpfiling\/AttachHis\/0062c62b-b124-472a-8148-baa7a1f61e66.pdf\" target=\"_blank\" rel=\"noopener\">Marginal Profit Decline<\/a><\/strong><strong>:<\/strong> Net profit fell by just over 9%, showing improved cost management partially offsetting steep revenue decline.<\/li>\n<li><strong>Market Position:<\/strong> As a relatively young company, Aarti Pharmalabs continues to grow its presence in pharmaceutical manufacturing with a focus on product quality and compliance.<\/li>\n<li><strong>Strategic Focus:<\/strong> The company is emphasizing operational efficiency, managing costs prudently, and reviving demand through focused marketing and customer engagement.<\/li>\n<\/ul>\n<h2><strong>Corporate Developments in Q1 FY26 Earnings<\/strong><\/h2>\n<p>The quarter <a href=\"https:\/\/www.bseindia.com\/xml-data\/corpfiling\/AttachHis\/0062c62b-b124-472a-8148-baa7a1f61e66.pdf\" target=\"_blank\" rel=\"noopener\">Q1 FY26<\/a> reflects a challenging operating environment for Aarti Pharmalabs Ltd, but disciplined expense control helped cushion the impact on profitability.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-170460\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APHARM.png\" alt=\"AARTIPAHRM Q1 FY26 Earnings Results\" width=\"1489\" height=\"1817\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APHARM.png 1489w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APHARM-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APHARM-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APHARM-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APHARM-1259x1536.png 1259w\" sizes=\"auto, (max-width: 1489px) 100vw, 1489px\" \/><\/p>\n<h2><strong>Looking Ahead<\/strong><\/h2>\n<p>Aarti Pharmalabs Ltd plans to stabilize revenue through new product launches, expanding its nutraceuticals portfolio, and optimizing manufacturing processes. Continued focus on cost control and market expansion is expected to support recovery in coming quarters.<\/p>\n<p>Explore the company\u2019s past earnings and latest concall transcripts,<a href=\"https:\/\/44.250.171.167\/symbol\/aartipharm\/\"> click here<\/a> to visit the AlphaStreet India News Channel.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aarti Pharmalabs Ltd, incorporated in 2019, is a manufacturer of pharmaceuticals and nutraceuticals. Presenting below are its Q1 FY26 Earnings Results. Q1 FY26 Earnings Results Revenue: \u20b9386 crore, down 30.45% year-on-year (YoY) from \u20b9555 crore in Q1 FY25. Total Expenses: \u20b9323 crore, down 33.26% YoY from \u20b9484 crore. Consolidated Net Profit (PAT): \u20b950 crore, down [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":170460,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[10162],"class_list":["post-170458","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APHARM.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":172328,"url":"https:\/\/alphastreet.com\/india\/aarti-pharmalabs-q2-fy26-earnings-results\/","url_meta":{"origin":170458,"position":0},"title":"Aarti Pharmalabs Q2 FY26 Earnings Results","author":"Divyansh_Kasana","date":"November 11, 2025","format":false,"excerpt":"Aarti Pharmalabs Ltd, incorporated in 2019 and engaged in manufacturing pharmaceuticals and nutraceuticals, reported its Q2FY26 financial results indicating challenges in profitability. Financial Highlights: Revenues declined 8.73% year-on-year to \u20b9418 crore from \u20b9458 crore. Total expenses decreased 2.81% to \u20b9380 crore from \u20b9391 crore. Consolidated net profit dropped 49.09% to\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Q2 FY26","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/AA.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/AA.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/AA.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/AA.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/AA.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/AA.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":170447,"url":"https:\/\/alphastreet.com\/india\/aarti-drugs-q1-fy26-earnings-results\/","url_meta":{"origin":170458,"position":1},"title":"Aarti Drugs Q1 FY26 Earnings Results","author":"Divyansh_Kasana","date":"August 21, 2025","format":false,"excerpt":"Aarti Drugs Ltd, established in 1984 and part of the $1000 million Aarti Group of Industries, is engaged in manufacturing and selling Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals, as well as pharmaceutical formulations. Presenting below are its Q1 FY26 Earnings Results. Q1 FY26 Earnings Results Revenue: \u20b9591 crore,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"AARTIDRUGS Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTOI.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTOI.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTOI.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTOI.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTOI.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTOI.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":166314,"url":"https:\/\/alphastreet.com\/india\/aarti-pharmalabs-ltd-q2fy25-6-rise-in-profits\/","url_meta":{"origin":170458,"position":2},"title":"Aarti Pharmalabs Ltd Q2FY25; 6% rise in Profits","author":"Divyansh_Kasana","date":"January 10, 2025","format":false,"excerpt":"Incorporated in 2019, Aarti Pharmalabs Ltd is a manufacturer of Pharmaceuticals and Nutraceuticals Financial Results: Aarti Pharmalabs Ltd reported Revenues for Q2FY25 of \u20b9458.00 Crores up from \u20b9440.00 Crore year on year, a rise of 4.09%. Total Expenses for Q2FY25 of \u20b9391.00 Crores up from \u20b9374.00 Crores year on year,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/H-1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/H-1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/H-1.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/H-1.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/H-1.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/H-1.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":169663,"url":"https:\/\/alphastreet.com\/india\/aarti-industries-ltd-q1-fy26-earnings-results-revenue-down-9-5-net-profit-plunges-69-yoy\/","url_meta":{"origin":170458,"position":3},"title":"Aarti Industries Ltd Q1 FY26 Earnings Results \u2013 Revenue Down 9.5%, Net Profit Plunges 69% YoY","author":"Divyansh_Kasana","date":"August 1, 2025","format":false,"excerpt":"Aarti Industries Limited, the flagship company of the Aarti Group, is a leading manufacturer of organic and inorganic chemicals with extensive production facilities across Gujarat (Vapi, Jhagadia, Dahej, Kutch) and Maharashtra (Tarapur). Renowned for its strong market position in NCB-based specialty chemicals, the company supplies key intermediates for diverse industries\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTI.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTI.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTI.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTI.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTI.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTI.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":159505,"url":"https:\/\/alphastreet.com\/india\/aarti-pharmalabs-ltd-q3fy24-10-rise-in-profits\/","url_meta":{"origin":170458,"position":4},"title":"Aarti Pharmalabs Ltd Q3FY24; 10% rise in Profits","author":"Divyansh_Kasana","date":"March 5, 2024","format":false,"excerpt":"Incorporated in 2019, Aarti Pharmalabs Ltd is a manufacturer of Pharmaceuticals and Nutraceuticals Financial Results: Aarti Pharmalabs Ltd reported Revenues for Q3FY24 of \u20b9449.00 Crores down from \u20b9472.00 Crore year on year, a fall of 4.87%. Total Expenses for Q3FY24 of \u20b9376.00 Crores down from \u20b9406.00 Crores year on year,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-41.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-41.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-41.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-41.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-41.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-41.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":157475,"url":"https:\/\/alphastreet.com\/india\/aarti-pharmalabs-ltd-q2fy24-2-rise-in-profits\/","url_meta":{"origin":170458,"position":5},"title":"Aarti Pharmalabs Ltd Q2FY24; 2% rise in Profits","author":"Divyansh_Kasana","date":"December 20, 2023","format":false,"excerpt":"Incorporated in 2019, Aarti Pharmalabs Ltd is a manufacturer of Pharmaceuticals and Nutraceuticals Financial Results: Aarti Pharmalabs Ltd reported Revenues for Q2FY24 of \u20b9440.00 Crores down from \u20b9531.00 Crore year on year, a fall of 17.14%. Total Expenses for Q2FY24 of \u20b9374.00 Crores down from \u20b9464.00 Crores year on year,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-148.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-148.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-148.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-148.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-148.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-148.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/170458","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=170458"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/170458\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/170460"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=170458"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=170458"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=170458"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}